ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

testosterone 17 beta-cypionate

Also written as “Testosterone Cypionate 75 mg”, “Testosterone cypionate 50 mg” and “Testosterone cypionate 100 mg”.

Its studies are mostly in Eunuchism, led by 2 companies.

Drug pageTestosterone 17 beta-cypionate: every studyAll 27 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Oct 21, 20262 company-led studies, 2 open or runningNext primary completion: Mar 31, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Amneal Pharmaceuticalsits history only11 open or runningphase 3since Oct 21, 2026Oct 21, 2026Mar 31, 2027phase 3 · NCT07898072
Azurity Pharmaceuticals11 open or runningphase 4since Jan 7, 2026Jan 7, 2026Jun 2027phase 4 · NCT07328542

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Azurity Pharmaceuticals only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 7, 2026First study: phase 4 study in EunuchismFirst studyNCT07328542 · 144 planned · United States

Ahead

  1. Jun 2027Primary completion: phase 4 study in EunuchismNCT07328542

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Azurity Pharmaceuticals leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07328542Eunuchism · United States4Not yet recruitingJun 2027144

How it is read

Names in the registry

  • “Testosterone Cypionate 75 mg”, 1 entry
  • “Testosterone cypionate 50 mg”, 1 entry
  • “Testosterone cypionate 100 mg”, 1 entry
  • “Testosterone Cypionate Injection 200 mg/mL”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.